Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forbes

Showing results (681-690 of 725) with videos related to

Pageof 73
Sort By:
Scientific Reports|May 27, 2016
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Internal Medicine Journal|November 6, 2014
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaS Xu, K Alexander, W Bryant, et al.
Emerging Infectious Diseases|April 20, 2019
Bombali Virus in Mops condylurus Bat, KenyaKristian M Forbes, Paul W Webala, Anne J Jääskeläinen, et al.
Scientific Reports|July 9, 2016
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Amino Acids|July 9, 2013
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjectsJosephine M Forbes, Karly C Sourris, Maximilian P J de Courten, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Nano Letters|October 26, 2021
Transition Metal Synthetic Ferrimagnets: Tunable Media for All-Optical Switching Driven by Nanoscale Spin CurrentMaciej Da Browski, Jade N Scott, William R Hendren, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Diabetes|May 31, 2008
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetesAino Soro-Paavonen, Anna M D Watson, Jiaze Li, et al.
Pageof 73

Showing results (681-690 of 725) with videos related to

Sort By:
Pageof 73
Scientific Reports|May 27, 2016
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Internal Medicine Journal|November 6, 2014
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaS Xu, K Alexander, W Bryant, et al.
Emerging Infectious Diseases|April 20, 2019
Bombali Virus in Mops condylurus Bat, KenyaKristian M Forbes, Paul W Webala, Anne J Jääskeläinen, et al.
Scientific Reports|July 9, 2016
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Amino Acids|July 9, 2013
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjectsJosephine M Forbes, Karly C Sourris, Maximilian P J de Courten, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Nano Letters|October 26, 2021
Transition Metal Synthetic Ferrimagnets: Tunable Media for All-Optical Switching Driven by Nanoscale Spin CurrentMaciej Da Browski, Jade N Scott, William R Hendren, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Diabetes|May 31, 2008
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetesAino Soro-Paavonen, Anna M D Watson, Jiaze Li, et al.
Pageof 73